520 results
Page 2 of 26
8-K
EX-99.1
xsh4v6xdf2un
10 Nov 22
Lisata Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
4:10pm
8-K
EX-99.2
91ega
10 Nov 22
Lisata Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
4:10pm
S-8
EX-99.1
ph4eto8ytgl5e gz
17 Oct 22
Registration of securities for employees
4:02pm
8-K/A
EX-99.1
o9e0w2j
4 Oct 22
Other Events
4:42pm
8-K/A
EX-99.3
5qjz zzplnlu9
4 Oct 22
Other Events
4:42pm
8-K/A
EX-99.2
jsaocs7t
4 Oct 22
Other Events
4:42pm
8-K
EX-99.1
jaajcdfl7nskic o2
22 Sep 22
Regulation FD Disclosure
4:02pm
8-K
EX-99.2
rdw0v5l7s68gda
15 Sep 22
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
9:16am
8-K
EX-10.2
kjbxehizd9 cbi2iu5
15 Sep 22
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
9:16am
8-K
EX-99.1
qnuvjw0xo33m1
15 Sep 22
Caladrius Biosciences and Cend Therapeutics Announce Closing of Merger and the Emergence of Lisata Therapeutics
9:16am
8-K
EX-99.1
6xkjt9b
14 Sep 22
Caladrius Biosciences Announces Approval of Merger and Name Change to Lisata Therapeutics
5:01pm
425
cgwouezhsl1jz dg
2 Sep 22
Business combination disclosure
4:01pm
425
ihb3paavrpvi4090n
15 Aug 22
Business combination disclosure
6:46am
425
1x6urkuez7a9
10 Aug 22
Business combination disclosure
8:08am
8-K
EX-99.1
uwtlsl
5 Aug 22
Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
4:01pm
8-K
EX-99.3
2rpxi83s7drmd7mwpzm
5 Aug 22
Caladrius Biosciences Reports Second Quarter 2022 Financial Results and Provides Business Update
4:01pm
424B3
5v4jgjtm5
29 Jul 22
Prospectus supplement
4:06pm